AstriVax
0 followers
‌
AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses... Read more
Industries
+1
Headquarters
Employees
Links
Org chart
Hanne Callewaert
CEO / Co-founder
Hanne Callewaert
Collapse
Barbara Freitag
Chief Financial Officer
Greg Fanning
Chief Business Officer
Mathieu Peeters
Chief Development Officer
Wilfried Dalemans
Chief Technical Officer (ad Interim)
Johan Neyts
Co-founder #astrivax
Isabelle Decoster
HR Lead
